New RSV Prevention Option for Newborns Wins EU Support – Medscape

Written by

admin

in

  1. New RSV Prevention Option for Newborns Wins EU Support  Medscape
  2. Merck & Co scores European and US wins for Keytruda  European Pharmaceutical Review
  3. FDA Approves Use of Subcutaneous Pembrolizumab for NSCLC | AJMC  The American Journal of Managed Care® (AJMC®)
  4. Merck Receives Positive EU CHMP Opinion for ENFLONSIA™ (clesrovimab) for the Prevention of Respiratory Syncytial Virus (RSV) in Infants During Their First RSV Season  BioSpace
  5. Merck Snags A Key Approval Before Its Cash Cow Goes Off A Patent Cliff  Investor’s Business Daily

Continue Reading

More posts